Recent advances in PEG–PLA block copolymer nanoparticles
RZ **ao, ZW Zeng, GL Zhou, JJ Wang… - International journal …, 2010 - Taylor & Francis
Due to their small particle size and large and modifiable surface, nanoparticles have unique
advantages compared with other drug carriers. As a research focus in recent years …
advantages compared with other drug carriers. As a research focus in recent years …
Biodegradable diblock copolymeric PEG-PCL nanoparticles: Synthesis, characterization and applications as anticancer drug delivery agents
Poly (ethylene glycol) methyl ether-block-poly (Ɛ-caprolactone) copolymers are useful
biomedical materials owing to their amphiphilic nature, biodegradability, biocompatibility …
biomedical materials owing to their amphiphilic nature, biodegradability, biocompatibility …
Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery
ZS Bayindir, N Yuksel - Journal of pharmaceutical sciences, 2010 - Elsevier
Nonionic surfactant based vesicles (niosomes) are novel drug delivery systems formed from
the self‐assembly of nonionic amphiphiles in aqueous media. In the present study niosomal …
the self‐assembly of nonionic amphiphiles in aqueous media. In the present study niosomal …
Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination
MC Chen, SF Huang, KY Lai, MH Ling - Biomaterials, 2013 - Elsevier
This study introduces a microneedle transdermal delivery system, composed of embeddable
chitosan microneedles and a poly (l-lactide-co-d, l-lactide)(PLA) supporting array, for …
chitosan microneedles and a poly (l-lactide-co-d, l-lactide)(PLA) supporting array, for …
Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake …
S Nie, WLW Hsiao, W Pan, Z Yang - International journal of …, 2011 - Taylor & Francis
Purpose To develop an in situ gel system comprising liposome-containing paclitaxel (PTX)
dispersed within the thermoreversible gel (Pluronic® F127 gel) for controlled release and …
dispersed within the thermoreversible gel (Pluronic® F127 gel) for controlled release and …
Accelerated in-vitro release testing methods for extended-release parenteral dosage forms
Objectives This review highlights current methods and strategies for accelerated in-vitro
drug release testing of extended-release parenteral dosage forms such as polymeric …
drug release testing of extended-release parenteral dosage forms such as polymeric …
Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors
Intraperitoneal (IP) chemotherapy is an effective way of treating local and regional
malignancies confined in the peritoneal cavity such as ovarian cancer. However, a …
malignancies confined in the peritoneal cavity such as ovarian cancer. However, a …
Multifunctional materials for bone cancer treatment
C Marques, JMF Ferreira, E Andronescu… - International journal …, 2014 - Taylor & Francis
The purpose of this review is to present the most recent findings in bone tissue engineering.
Special attention is given to multifunctional materials based on collagen and collagen …
Special attention is given to multifunctional materials based on collagen and collagen …
κ-Carrageenan hydrogel nanocomposites with release behavior mediated by morphological distinct Au nanofillers
AM Salgueiro, AL Daniel-da-Silva, S Fateixa… - Carbohydrate …, 2013 - Elsevier
In this work we investigate the effect of spherical and rod-shaped Au nanoparticles (NPs) in
the microstructure, thermomechanical and release properties of thermosensitive κ …
the microstructure, thermomechanical and release properties of thermosensitive κ …
Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent
L De Smet, W Ceelen, JP Remon… - The Scientific World …, 2013 - Wiley Online Library
Intraperitoneal (IP) chemotherapy is an effective way of treating peritoneal carcinomatosis of
colorectal origin after complete cytoreduction. Although IP therapy has been already …
colorectal origin after complete cytoreduction. Although IP therapy has been already …